Effects of the use of carvedilol in dilated cardiomyopathy in pediatric age
Abstract
Introduction: dilated cardiomyopathy is the most common worldwide cardiomyopathy. In pediatric patients, the annual incidence is 0.5-1.2 cases per 100,000, with 8-12 times more common presentation in infants (4.4 per 100,000) than in older children. Considering the limited prognosis of long-term cardiac transplantation and absence of adequate pediatric donors, all strategies that seek to improve current medical treatments and investigate alternative therapeutic options are justified.
Development: a bibliographic review was carried out with the aim of knowing the use effects of carvedilol in dilated in pediatric age. Dilated cardiomyopathy is characterized by a massive cardiomegaly secondary to wide enlarged ventricles. The prevalence in the child population is 36.5 per 100 000 live births, aggressive treatment of heart failure can make a temporary remission, but relapses are common and patients that tend to become resistant to the usual medication. Conclusions: the introduction of carvedilol in the pediatric treatment of these diseases is relatively new, and requires a study of the issue further.
Downloads
Published
How to Cite
Issue
Section
License
MediCiego does not apply publication charges. The journal is available in open access without restrictions, in compliance with the international policy on open access to information for the exchange of global knowledge.
The authors will retain their copyright and guarantee the journal the right of first publication of their work. MediCiego is licensed under the Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES), so it is allowed to copy, reproduce, distribute, publicly communicate the work and generate derivative works, as long as the original author is cited and acknowledged. However, it is not allowed to use the original work for commercial or lucrative purposes.
Authors must sign a copyright agreement through an affidavit of authorship and originality, before publishing.
The authors authorize the publication of their writings; they retain the copyright, and assign to the journal all the rights protected by the Copyright Law that governs Cuba, and implies the edition to disseminate the work.
Likewise, they may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with the recognition of having been first published in this journal.
Declaration of authorship: download here the Affidavit
